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Abstract – The replication of porcine reproductive and respiratory syndrome virus (PRRSV) in lungs and
lymphoid tissues of PRRSV-infected pigs is already strongly reduced before the appearance of neutralizing
antibodies, indicating that other immune mechanisms are involved in eliminating PRRSVat those sites. This
study aimed to determine whether PRRSV Lelystad virus (LV)-speciﬁc cytotoxic T-lymphocytes (CTL) can
efﬁciently eliminate PRRSV-infected alveolar macrophages. Therefore, CTL assays were performed with
PRRSV-infected alveolar macrophages as target cells and autologous peripheral blood mononuclear cells
(PBMC) from PRRSV-infected pigs as a source of PRRSV-speciﬁc CTL. PBMC of 3 PRRSV-infected pigs
were used either directly in CTL assays, or following restimulation in vitro. CTL assays with pseudorabies
virus (PRV) Begonia-infected alveolar macrophages and autologous PBMC, from 2 PRV Begonia-
inoculated pigs, were performed for validation of the assays. In freshly isolated PBMC, derived from
PRRSV-infected pigs, CTL activity towards PRRSV-infected macrophages was not detected until the end of
the experiment (56 days post infection – dpi). Restimulating the PBMC with PRRSV in vitro resulted in
proliferation of CD3+CD8high cells starting from 14 dpi. Although CD3+CD8high cells are generally
considered to be CTL, CTL activity was not detected in PRRSV-restimulated PBMC of the 3 pigs until 49
dpi. Aweak PRRSV-speciﬁc CTL activity was observed only at 56 dpi in PRRSV-restimulated PBMC of one
pig. In contrast, a clear CTL activity was observed in PRV Begonia-restimulated PBMC, derived from PRV
Begonia-infected pigs, starting from 21 dpi. This study indicates that PBMC of PRRSV-infected pigs contain
proliferating CD3+CD8high cells upon restimulation in vitro, but these PBMC fail to exert CTL activity towards
PRRSV-infected alveolar macrophages.
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1. INTRODUCTION
Porcine reproductive and respiratory syn-
drome (PRRS) is characterized by reproductive
failure in sows and is associated with the respi-
ratory disease complex affecting pigs of all ages
[14, 59, 60]. The causative agent, PRRS virus
(PRRSV), belongs to the family Arteriviridae,
order Nidovirales [10]. In vivo, the virus infects
subsets of pig macrophages that are mainly
present in lungs and lymphoid tissues [20].
The pathogenesis of PRRSV infection is char-
acterized by a high level of viremia for 1 to 2
weeks, followed by a low level of viremia for
another 2 to 3 weeks. Subsequently, low levels
of PRRSV may persist in lymphoid tissues for
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several months [4, 20, 62], but ﬁnally, PRRSV
is eliminated from most pigs within 2 to 4
months [4, 20, 31, 62]. Up till now, it is not
fully elucidated which immune mechanisms
cause (i) a drop in virus replication in lungs
and lymphoid tissues after 2 weeks of infection,
(ii) complete elimination of the virus from the
blood after 4 to 5 weeks of infection and (iii)
complete elimination of the virus from the
lungs and lymphoid tissues within 2 to 4
months.
PRRSV elicits an immune response that dif-
fers from the immune response induced by
other viral swine pathogens like swine inﬂuenza
virus or pseudorabies virus (PRV). PRRSV-
speciﬁc non-neutralizing antibodies are quickly
induced starting from 7 days post infection
(dpi), but low titres of virus-neutralizing anti-
bodies are only detected starting from 25–35
dpi [31, 37]. In some pigs, low levels of
PRRSV replication are still found in lungs
and lymphoid tissues in the presence of neutral-
izing antibodies [31], indicating that other
immune mechanisms are involved in the com-
plete elimination of PRRSV at those sites. The
adaptive cell-mediated immune response is
described to play a critical role in the resolution
of many virus infections and is exerted by cyto-
toxic T-lymphocytes (CTL) and T helper (Th)
lymphocytes, in cooperation with Th1-activated
natural killer cells (NK) and macrophages.
PRRSV infection induces T-lymphocyte medi-
ated immune responses starting from 2 to 4
weeks pi, as assessed by in vitro proliferation
assays, in vitro IFNc ELISPOT assays and
in vivo delayed type hypersensitivity assays
[7, 8, 36, 41]. An inversed correlation has been
described between the number of CD3+CD8high
cells and PRRSV persistence in lymphoid
organs [32]. Therefore, it has been suggested
that CTL may play an important role in the
reduction of virus replication in lungs and
lymphoid tissue after 2 weeks of infection and
in the complete clearance of PRRSV infection
after 2 to 4 months. However, the contribution
of the CTL in the elimination of PRRSV-
infected cells has never been investigated. This
study aimed to determine whether PRRSV-
speciﬁc CTL are able to eliminate PRRSV-
infected macrophages.
2. MATERIALS AND METHODS
2.1. Viruses
A 5th passage of PRRSV Lelystad virus (LV) [59,
60] on speciﬁc-pathogen-free alveolar macrophages
was used for experimental inoculations of pigs.
A 13th passage of LV on alveolar macrophages was
used for in vitro restimulation of peripheral blood
mononuclear cells (PBMC) and for in vitro inocula-
tion of target cells. A PRV vaccine strain was
included in this study for validation of the tests:
a 2nd passage on swine testicle (ST) cells of PRV
Begonia [57] was used for experimental inoculations
of pigs, for in vitro restimulation of PBMC and for
in vitro inoculation of target cells.
2.2. Animals and experimental design
Five 6-week-old pigs from a PRV- and PRRSV-
negative farm were used. Alveolar macrophages were
collected from each pig, by performing in vivo lung
lavages. Brieﬂy, the pigs were completely anesthe-
tized (mixture of Zoletil-100, Virbac Animal Health,
Barneveld, Netherlands; and Xyl-M 2%, VMD,
Arendonk, Belgium) and a 40 cm catheter (3 mm
diameter) was carefully slid through the trachea into
a lung lobe. Lungs were lavaged with phosphate-
buffered saline (PBS, 37 C) and the cells obtained
were mainly macrophages (> 90%). The macro-
phages were aliquoted and stored in liquid N2 until
use. At 13 weeks of age, 3 pigs (pigs 1, 2 and 3) were
inoculated oronasally with LV (2 · 106 TCID50 in
8 mL PBS). Two pigs (pigs 4 and 5) were oronasally
inoculated with PRV Begonia (2 · 107 TCID50 in
8 mL PBS). Blood was sampled at 0, 1, 3, 6, 9,
14, 21, 28, 35, 42, 49 and 56 dpi for collection of
serum and/or isolation of PBMC. In this study, only
a small number of pigs was used for both ethical
aspects and the large amount of parameters that had
to be examined at the same time. The experiments
were approved by the Ethical and Animal welfare
Committee of the Faculty of Veterinary Medicine
of Ghent University (EC2007/097).
2.3. Virus isolation and titration and serological
examination
Virus was isolated and titrated from serum or
nasal swabs on alveolar macrophages (PRRSV; pigs
1, 2 and 3) or ST cells (PRV Begonia; pigs 4 and 5).
Heat-inactivated sera were tested for the presence
of antibodies against PRRSV (pigs 1, 2 and 3) or
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PRV Begonia (pigs 4 and 5) in an immunoperoxidase
monolayer assay (IPMA) as described by Wensvoort
et al. [59] on respectively methanol-ﬁxed PRRSV-
infected Marc-145 cells and methanol-ﬁxed PRV
Begonia-infected ST cells. In addition, the sera were
tested for the presence of virus-neutralizing antibod-
ies as described by Labarque et al. [31] for PRRSV,
and as described by Andries et al. [5] for PRV.
2.4. Isolation and culture of PBMC
for proliferation assays and CTL assays
PBMC were puriﬁed by density centrifugation
over Ficoll-Paque (Pharmacia Biotech, Roosendaal,
Netherlands). The cells obtained were either
paraformaldehyde-ﬁxed for examining proportions
of CD3+CD8high cells, either directly used in
CTL assays or exposed to recall antigen (virus)
in vitro (restimulation) to expand in vivo-primed
virus-speciﬁc lymphocytes. Prior to restimulation,
PBMC were adjusted to a concentration of 4 · 106
viable cells/mL medium and seeded in upright
75 cm2 ﬂasks. The medium consisted of a 1:1 mix-
ture of AIM-V serum-free lymphocyte medium
(Gibco, Merelbeke, Belgium) and RPMI 1640
medium, supplemented with foetal bovine serum
(10%), L-glutamine (2 mM), non-essential amino
acids (50 lM each), sodium pyruvate (500 lM),
2-mercaptoethanol (55 lM), gentamicin (50 lg/
mL), penicillin (100 U/mL), streptomycin (100 lg/
mL). PBMC were restimulated by adding
semi-puriﬁed [17] cell-free PRRSV (m.o.i. of 1),
PRV Begonia (m.o.i. of 1) or mock-control to the
cells at one day post seeding. Restimulated PBMC
were either used for determination of the amount of
lymphocyte proliferation, for determination of pro-
portions of CD3+CD8high cells, or used as a source
of effector cells in CTL assays.
2.5. Lymphocyte proliferation assay
After 5 days of restimulation with virus or
mock-control, PBMC were cytocentrifuged, parafor-
maldehyde-ﬁxed and permeabilized with 0.1% Triton
X-100. In vitro proliferation of in vivo-primed virus-
speciﬁc CD8high cells was determined by immunoﬂu-
orescence stainings for both Ki-67 and CD8 antigens.
Ki-67 is a short-living nuclear non-histone protein of
which the expression is strictly associatedwith cell pro-
liferation [24]. In short, cell smearswere incubatedwith
mAb MONX10284 (Monosan, Uden, Netherlands)
directed against Ki-67 andwith TexasRed-labeled goat
anti-mouse IgG (Molecular Probes, Merelbeke,
Belgium). Free goat anti-mouse binding sites were
blocked with 10% mouse serum in PBS. Next, cell
smears were incubated with FITC-labeled anti-CD8a
mAb (76-2-11; Becton Dickinson PharMingen,
Erembodegem, Belgium). The stainingswere analyzed
byﬂuorescencemicroscopy.For eachcondition, at least
2000 PBMC were analyzed. Generally, a CD8high
phenotype is considered to be speciﬁc for CTL [46].
Therefore, PBMC that were positive for both CD8high
and Ki-67 were considered as proliferating CTL.
2.6. Flow cytometric analysis of the
CD3+CD8high cell subset in mock-
and virus-restimulated PBMC
Paraformaldehyde-ﬁxed PBMC were double-
stained for CD3 and CD8 by incubating the cells with
mAb against CD3 (BB23-8E6; Becton-Dickinson
PharMingen) and with Cy5-labeled goat anti-mouse
IgG (Zymed Laboratories, San Francisco, CA,
USA). Free goat anti-mouse binding sites were
blocked with 10% mouse serum in PBS. Next,
PBMC were incubated with FITC-labeled anti-
CD8a mAb (76-2-11; Becton Dickinson PharMin-
gen). At least 10 000 cells/sample were analyzed
with a Becton-Dickinson FACScanto, equipped with
a Sapphire Coherent solid state laser (488 nm) and a
JDS Uniphase HeNe laser (633 nm). FACSDIVA 5.0
software was used for analysis of the samples.
2.7. CTL assay
2.7.1. Target cells
Autologous alveolar macrophages, obtained by
in vivo lung lavages of pigs prior to inoculation, were
used as target cells. The cells were cultured for 72 h
prior to inoculation with PRRSV or PRV Begonia at
an m.o.i. of 10. At 6 hpi, the macrophages were
labeled with a ﬂuorescent lipophilic membrane mar-
ker, 3,30-dioctadecyloxacarbocyanine (Dio, Invitro-
gen). Preliminary analysis showed that this
membrane marker had no effect on cell viability
and virus replication. At 7 hpi, viable macrophages
were counted and used as autologous target cells in
the CTL assays. The percentage of PRRSV-positive
macrophages varied between 30 and 60%; the
percentage of PRV Begonia-positive macrophages
varied between 70 and 80%.
2.7.2. Effector cells
Viable PBMC were counted and used as a source
of effector cells. PBMC were either used immediately
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after isolation, or after restimulation with virus
for 6 days.
2.7.3. CTL assay
Dio-labeled virus-infected alveolar macrophages
were seeded in 96-well plates together with serial
dilutions of autologous effector cells so that effec-
tor:target (E:T) ratios 100:1, 30:1, 0:1 were achieved.
Experiments were performed in triplicate. After 4 h
of incubation at 37 C, cell death was assessed at a
single cell level: dead cells were labeled with ethi-
dium bromide monoazide (EMA, Invitrogen), a ﬂuo-
rescent vital dye; the cells were ﬁxed with
paraformaldehyde and permeabilized with 0.1%
saponin (Sigma). Virus-infected cells were stained
with biotinylated PRRSV-speciﬁc polyclonal anti-
bodies [15] or biotinylated PRV-speciﬁc polyclonal
antibodies [22] and Alexaﬂuor350-labeled streptavi-
din (Molecular Probes). Dead (EMA-positive)
virus-infected target cells were counted using ﬂuores-
cence microscopy. Cytolytic activity was calculated
by subtracting the percentage of dead virus-infected
target cells at E:T ratio 0:1 from the percentage of
dead virus-infected target cells at E:T ratio’s 100:1
or 30:1. MHC-I-restriction of lysis was assessed in
two ways: (i) CTL assays were performed with heter-
ologous alveolar macrophages derived by lung lavag-
es of a non-related pig and (ii) CTL assays were
performed with virus-infected target cells that were
incubated for 30 min on ice with mAb directed
against MHC-I (50 lg/mL; PT85A, VMRD Inc.,
Pullman, WA, USA) prior to the CTL assay. The iso-
type-matched anti-PCV2 mAb 16G12 [34] was used
as isotype control in the MHC-I-blocking assay.
PRRSV-speciﬁcity of observed cytotoxic activity
was assessed in CTL assays with PBMC of the
PRRSV-infected pigs and autologous alveolar
macrophages that were in vitro inoculated with PRV
Begonia instead of PRRSV. Similarly, PRV Begonia-
speciﬁc cytotoxic activity was determined in CTL
assays with PBMC of the PRV Begonia-infected pigs
and autologous macrophages that were in vitro
infected with PRRSV.
2.8. Determination of IFNc production by virus-
or mock-restimulated PBMC derived from
virus-infected pigs
The supernatant ﬂuids of mock- and virus-
restimulated PBMC (6 days of restimulation) were
collected for determination of IFNc levels. Therefore,
a commercially available IFNc ELISA (Biosource,
Merelbeke, Belgium) was used.
3. RESULTS
3.1. Detection of viremia and humoral immune
response following exposure to PRRSV
or PRV Begonia
As shown in Figure 1, infectious PRRSV
was detected in serum of the 3 PRRSV-inocu-
lated pigs until 14 (pigs 2 and 3) or 21 (pig 1)
dpi. On day 9 pi, all 3 PRRSV-infected pigs
had seroconverted for PRRSV as shown by
IPMA. PRRSV-neutralizing antibodies were
detected starting from 21 (pig 3) or 28 (pigs 1
and 2) dpi. PRV Begonia could not be isolated
from the PRV Begonia-inoculated pigs, neither
from serum, nor from nasal swabs, though the
PRV Begonia-inoculated pigs seroconverted
for PRV Begonia at 9 dpi and PRV Begonia-
speciﬁc neutralizing antibodies were also
detected starting from 9 dpi.
3.2. CTL assay with freshly isolated PBMC
At 0, 7, 14, 21, 28, 35, 42, 49 and 56 dpi,
only negligible levels of cytolytic activity (not
more than 4.6% lysis, average of 3 pigs)
towards autologous PRRSV-infected alveolar
macrophages were detected in freshly isolated
PBMC derived from PRRSV-infected pigs
(data not shown). Similar levels of lysis were
observed when PRRSV-infected heterologous
macrophages or PRV Begonia-infected autolo-
gous macrophages were used in the CTL assays
(data not shown), indicating that the low level
of cytolytic activity was not MHC-I-restricted
and not speciﬁc for PRRSV.
Similarly, freshly isolated PBMC, derived
from PRV Begonia-infected pigs at 0, 7, 14,
21, 28, 35, 42, 49 and 56 dpi poorly (not more
than 6.4% lysis) and non-speciﬁcally lysed
PRV Begonia-infected macrophages in a non-
MHC-I-restricted way (data not shown).
3.3. In vitro proliferation of in vivo-primed
virus-speciﬁc CD3+CD8high cells
Since a virus-speciﬁc CTL activity was not
detected in freshly isolated PBMC, neither for
PRRSV, nor for PRV Begonia, PBMC were
restimulated in vitro prior to the CTL assay.
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As shown in Figure 2, mock-restimulation of
PBMC of PRRSV-infected pigs resulted in neg-
ligible levels of CD8high cell proliferation until
the end of the experiment (0.0 to 0.6%
Ki-67+CD8high cells), with the exception of pig
3 at 42 dpi. Restimulation of the PBMC with
PRRSV resulted in a CD8high cell proliferation
response starting from 14 dpi. This proliferation
response increased starting from 42 dpi until the
end of the experiment (respectively 3.8%, 4.2%
Figure 1. Time course of virus titres (A, D), IPMA antibody titres (B, E) and virus-neutralizing antibody
titres (C, F) in sera of PRRSV-infected pigs (A, B, C) and PRV Begonia-infected pigs (D, E, F). Full
symbols represent individual pig values (j pig 1, d pig 2, m pig 3,  pig 4, pig 5). Full lines represent
average values of the pigs.
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and 4.6% Ki-67+CD8high cells at 42, 49 and
56 dpi). In the cultures of PRRSV-restimulated
PBMC, PRRSV-infected monocytes seemed to
be responsible for the presentation of PRRSV
antigens via MHC-I towards PRRSV-speciﬁc
CD8high cells, since (i) at day 1 of the restimula-
tion, 1 to 2% of themonocytes was infected with
PRRSV; and (ii) restimulation of the PBMCwith
UV-inactivated PRRSV resulted only in back-
ground CD8high cell proliferation levels (0.5 to
0.9%; data not shown).
The CD8high cell proliferation response
appeared to be PRRSV-speciﬁc, since restimu-
lation with PRV Begonia only resulted in back-
ground CD8high cell proliferation levels (0.3 to
0.8% Ki-67+CD8high cells; data not shown).
Restimulation with PRV Begonia of PBMC
derived from PRV Begonia-infected pigs
resulted in CD8high cell proliferation starting
from 14 dpi until the end of the experiment, with
maxima at 21 dpi (3.9% Ki-67+CD8high cells)
and 42 dpi (3.4% Ki-67+CD8high cells). This
proliferation response was PRV Begonia-
speciﬁc since restimulation of these PBMC
with PRRSV resulted in background levels
of CD8high cell proliferation (0.2 to 0.6%
Ki-67+CD8high cells; data not shown).
3.4. Flow cytometric analysis
of the CD3+CD8high cell subset
in virus- or mock-restimulated PBMC
As shown in Figure 2, in vitro restimulation
with virus of PBMC derived from virus-infected
pigs resulted in a CD8high cell proliferation
response. To evaluate the effect of restimulation
on the proportion of CD3+CD8high cells in the
PBMC, virus- and mock-restimulated PBMC
were stained for CD3 and CD8. Restimulation
with PRRSV of PBMC derived from PRRSV-
infected pigs resulted in an increased percentage
of CD3+CD8high cells starting from 14 dpi com-
pared to mock-restimulation (Fig. 3A).
PRVBegonia restimulation of PBMCderived
from PRV Begonia-infected pigs resulted in an
increased percentage of CD3+CD8high cells start-
ing from 7 dpi, compared to mock-restimulation
(Fig. 3B).
3.5. CTL assay with virus-restimulated PBMC
Figure 4 shows the percentages of lysed
virus-infected target cells at an E:T ratio of
100:1. PRRSV-restimulated PBMC derived
from PRRSV-infected pigs possessed no
Figure 2. Time course of the percentage of proliferating CD8high cells in PBMC that were derived from
virus-infected pigs and that were restimulated in vitro with virus or mock-control. A shows data for PRRSV-
infected pigs; B for PRV Begonia-infected pigs. Full symbols represent individual pig values after
restimulation with virus (j pig 1, d pig 2, m pig 3,  pig 4, pig 5); empty symbols represent individual
pig values after mock-restimulation (h pig 1, O pig 2, D pig 3, e pig 4, x pig 5). Each symbol represents
the mean of 3 repetitions in an individual pig; full lines represent average values for the pigs obtained after
restimulation with virus; dashed lines represent average values for the pigs obtained after mock-
restimulation.
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considerable levels of cytolytic activity towards
PRRSV-infected autologous macrophages (2.0
to 8.9% average lysis of 3 pigs). To evaluate
the MHC-I-restriction and the virus-speciﬁcity
of this low level of cytolysis, 3 controls were
used: CTL assays with PRRSV-infected heter-
ologous macrophages, CTL assays with autolo-
gous macrophages that were incubated with
anti-MHC-I mAb or its isotype control and
CTL assays with PRV Begonia-infected autolo-
gous macrophages. Compared to each other,
these control assays revealed similar levels of
target cell lysis, indicating that the negligible
levels of lysis were non-MHC-I-restricted and
not virus-speciﬁc. Only at 56 dpi, a low level
of PRRSV-speciﬁc, MHC-I-restricted cytotox-
icity towards PRRSV-infected macrophages
was detected in PRRSV-restimulated PBMC
of one pig (pig 1).
In contrast, PRV Begonia-restimulated
PBMC derived from PRV Begonia-infected
pigs lysed PRV Begonia-infected autologous
macrophages efﬁciently (14.5 to 28.1% average
lysis of two pigs) starting from 21 dpi. Cytotox-
icity towards PRV Begonia-infected autologous
macrophages was considerably higher than
cytotoxicity towards PRV Begonia-infected het-
erologous macrophages and than cytotoxicity
towards PRV Begonia-infected autologous tar-
get cells, incubated with anti-MHC-I mAb. In
addition, cytotoxicity towards PRV Begonia-
infected autologous macrophages was higher
than cytotoxicity towards PRRSV-infected
autologous target cells. This indicates that
PRV Begonia-restimulated PBMC possess
cytolytic activity towards PRV begonia-infected
macrophages in a MHC-I-restricted and virus-
speciﬁc way.
3.6. Production of IFNc by virus- and mock-
restimulated PBMC derived from virus-
infected pigs
In addition to cytolytic activity, the produc-
tion of IFNc by virus- and mock-restimulated
PBMC was also examined. Mock-restimulated
PBMC derived from PRRSV-inoculated pigs
at 0 to 56 dpi, produced negligible amounts
of IFNc (Fig. 5). The average amount of IFNc
produced by PRRSV-restimulated PBMC
derived from PRRSV-infected pigs at 0 dpi
was remarkably high (726 pg per 4 · 106 cells)
compared to the average amount of IFNc pro-
duced by PRV Begonia-restimulated PBMC
derived from the PRV Begonia-infected pigs
at 0 dpi (193 pg per 4 · 106 cells). This high
Figure 3. Time course of proportions of CD3+CD8high cells in PBMC that were derived from virus-infected
pigs and that were in vitro restimulated with virus or mock-control. A shows data for PRRSV-infected pigs;
B for PRV Begonia-infected pigs. Full symbols represent individual pig values after restimulation with virus
(j pig 1, d pig 2, m pig 3,  pig 4, pig 5); empty symbols represent individual pig values after mock-
restimulation (h pig 1, O pig 2, D pig 3, e pig 4, x pig 5). Full lines represent average values of the pigs
obtained after restimulation with virus. Dashed lines represent average values for the pigs obtained after
mock-restimulation.
Impairment of PRRSV-speciﬁc CD3+CD8high cells Vet. Res. (2009) 40:46
(page number not for citation purpose) Page 7 of 15
Figure 4. Time course of cytolytic activity of virus-restimulated PBMC (derived from virus-infected pigs)
towards autologous virus-infected macrophages (A, E), towards heterologous virus-infected macrophages
(B, F), towards autologous macrophages that were infected with another virus (C, G) or towards autologous
virus-infected macrophages, that were incubated with anti-MHC-I antibodies (D, H). A, B, C and D show
data for PRRSV-infected pigs; E, F, G and H show data for PRV Begonia-infected pigs. Full symbols
represent individual pig values (j pig 1, d pig 2, m pig 3,  pig 4, pig 5). Each symbol represents the
mean of 3 repetitions in an individual pig. Full lines represent average values of the pigs.
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average value was caused by the high IFNc pro-
duction of the PBMC of pigs 1 and 2 (both
1 040 pg per 4 · 106 cells). The general IFNc
production was strongly reduced at later time
points until the end of the experiment, except
for pig 1, whose PBMC still produced high
amounts of IFNc at 7 dpi, and again at 56 dpi.
Mock-restimulated PBMC derived from PRV
Begonia-inoculated pigs at 0 to 56 dpi produced
negligible amounts of IFNc. PRV Begonia-
restimulated PBMC derived from PRV-
inoculated pigs produced IFNc at all examined
time points. The highest IFNc levels were pro-
duced by restimulated PBMC that were isolated
from the pigs at 21 and 28 dpi (respectively
392.0 and 521.5 pg per 4 · 106 cells).
4. DISCUSSION
PRRSV replicates to high levels in lungs and
lymphoid tissues, resulting in an extensive vire-
mia during 2 weeks. Afterwards, the virus rep-
licates at low levels for several weeks more. In
some pigs, virus may persist for months, despite
the presence of neutralizing antibodies [7, 31].
Until now, the role of CTL in the control of
PRRSV replication was not investigated. In this
study, CTL assays were performed with freshly
isolated or PRRSV-restimulated PBMC deri-
ved from PRRSV-infected pigs as source of
PRRSV-speciﬁc CTL and autologous PRRSV-
infected alveolar macrophages as target cells.
Previously, Kawashima et al. [28] reported
an increased number of CD8+ T-lymphocytes
in periarteriolar lymphoid sheets of the spleen
and in the paracortex of superﬁcial inguinal
lymph nodes of PRRSV-infected pigs, starting
from 10 dpi. Other studies describe an inﬂux
of CD8+ T-lymphocytes in the blood, lungs
and medial retropharyngeal lymph nodes of
infected pigs, starting from 10 to 24 dpi
[3, 33, 49, 50]. This suggests that PRRSV-
speciﬁc CD8+ T-lymphocytes migrate from
lymphoid sites of initial activation to sites of
antigen deposition. Upon infection with PRRSV,
an increased proportion of CD3+CD8high cells in
freshly isolated PBMCwas also observed in this
study (data not shown), butCTL activity towards
PRRSV-infected macrophages was not detected
in these freshly isolated PBMC (data not shown).
CTL activity was also not detected in freshly
isolated PBMC derived from PRV Begonia-
infected pigs in accordance with a study of
De Bruin et al. [16]. Most likely, this is due to
Figure 5. Time course of IFNc production by virus-restimulated or mock-restimulated PBMC that were
derived from virus-infected pigs. A shows data for PRRSV-infected pigs; B for PRV Begonia-infected pigs.
Full symbols represent individual pig values of IFNc production by PBMC after restimulation with virus
(j pig 1, d pig 2, m pig 3,  pig 4, pig 5); empty symbols represent individual pig values of IFNc
production by PBMC after mock-restimulation (h pig 1, O pig 2, D pig 3, e pig 4, x pig 5). Full lines
represent average values for the pigs obtained after restimulation with virus. Dashed lines represent average
values for the pigs obtained after mock-restimulation.
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a low number of virus-speciﬁc CTL in the
peripheral blood at the time points of blood
collection [16, 21]. The sample time point
appears to be a critical factor for the detection
of direct CTL effector activity in the peripheral
blood, since speciﬁc effector CTL are present
in the blood for only a short period of time
(own observation by B. Goddeeris).
Restimulating PBMC, derived from
PRRSV-infected pigs, with PRRSV in vitro
resulted in proliferation of CD8high cells starting
from 14 dpi, and in an increased proportion
of CD3+CD8high cells. However, PRRSV-
speciﬁc MHC-I-restricted cytolytic activity
towards PRRSV-infected macrophages was not
detected in these PBMC, except for pig 1 at
56 dpi. In contrast, PRV Begonia-restimulated
PBMC derived from PRVBegonia-infected pigs
possessed a clear CTL activity towards PRV
Begonia-infected macrophages, which proves
the well-functioning of the CTL assay technique
used. Different hypotheses can be formulated to
explain the observed lack of CTL activity: either
(i) PRRSV-infected macrophages are not recog-
nized by CTL, or (ii) PRRSV-infected macro-
phages are resistant to CTL-mediated lysis, or
(iii) the responding CD3+CD8high cells are not
PRRSV-speciﬁc CTL, or (iv) PRRSV-speciﬁc
CTL are functionally impaired.
CTL recognize virus-infected cells via sur-
face MHC-I molecules carrying viral peptides.
In order to escape CTL-mediated lysis, many
viruses have evolved strategies to interfere with
the MHC-I pathway [26]. In this study, down-
regulation of surface MHC-I molecules was
not observed in PRRSV-positive macrophages
(data not shown). However, whether PRRSV
peptides were loaded onto the MHC-I mole-
cules was not determined.
CTL eliminate their target cells by inducing
apoptosis via the death receptor-mediated and/
or the granzyme-mediated apoptosis pathway.
Many viruses have developed strategies to inter-
fere with these apoptosis pathways to protect
infected cells against CTL-mediated elimination
[6]. In this study, PRRSV-infected target cells
were susceptible to lytic activity exerted by
PRV Begonia-restimulated PBMC derived from
PRV Begonia-infected pigs. This suggests
that PRRSV-infected macrophages are not
resistant to death receptor and/or granzyme-
induced apoptosis, since it demonstrates
susceptibility of PRRSV-infected macrophages
towards NK activity, which is also exerted via
death receptor and/or granzyme-induced
apoptosis [27].
It cannot be excluded that the proliferating
CD3+CD8high cells that were only detected
upon restimulation with PRRSV, are not
PRRSV-speciﬁc CTL. In vitro restimulation
with PRRSV induced CD4+ T-lymphocyte
proliferation (7 to 15% proliferating CD4+ cells;
data not shown), which may have induced
aspeciﬁc cytokine-mediated proliferation of
CD3+CD8high cells as a bystander effect [54].
It is also possible that the observed prolifer-
ating CD3+CD8high cells are PRRSV-speciﬁc
CTL, but with an impaired effector function.
Functional impairment of CTL is a common
viral immune evasion mechanism and several
virus-mediated mechanisms causing CTL
impairment have been described [1, 9, 25, 30,
39, 43, 45, 47, 64]. Dendritic cells, which are
the most important antigen-presenting cells,
play a crucial role in the activation of naı¨ve
CTL [27]. Some viruses, like herpes simplex
virus-1, human cytomegalovirus and hepatitis
B virus, can render dendritic cells ineffective
in stimulating T-lymphocytes [9, 43, 47].
Recent in vitro studies show that PRRSV repli-
cates in certain subsets of dendritic cells, down-
regulates MHC-I, MHC-II and CD80/CD86
surface expression in these cells and induces
dendritic cell apoptosis and necrosis at the
end of the replication cycle [11, 23, 38, 58].
Up till now, it is not known whether these ﬁnd-
ings also account for the in vivo situation.
Nevertheless, they suggest that PRRSV impairs
the dendritic cell-mediated antigen-presenting
function towards naı¨ve CD8+ T-lymphocytes,
which may result in an aberrant stimulation of
naı¨ve CD8+ T-lymphocytes and an aberrant
CTL development. In addition to antigen and
co-stimulation, CD8+ T-lymphocytes require
cytokines like IFNa and IL12 for optimal
generation of effector and memory cells [42].
However, PRRSV replication does not induce
or even suppresses signiﬁcant IFNa production
[2, 56], which also might contribute to an
aberrant CTL development.
Vet. Res. (2009) 40:46 S. Costers et al.
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CTL impairment can also be caused by the
continuous presence of viral antigen and the
consequent continuous activation of virus-
speciﬁc immune cells which results in func-
tional exhaustion or even physical depletion
of virus-speciﬁc CTL clones [61, 64], or in a
general CTL suppression by the induction of
regulatory T-lymphocytes [39, 48, 55]. PRRSV
can persist in PRRSV-infected pigs for several
months [4, 20, 31, 62], thereby possibly stimu-
lating PRRSV-speciﬁc immune cells for an
extended period. Similarly to what is observed
in chronic lymphocytic choriomeningitis virus
and human immunodeﬁciency virus infections
[30, 64], it is possible that virus-speciﬁc prolif-
erating, but regulatory T-lymphocyte-mediated
functionally impaired CD3+CD8high cells are
also present during PRRSV infection. This
hypothesis is in agreement with the recently
described PRRSV-mediated induction of regu-
latory T-lymphocytes [51], and by the fact that
PRRSV stimulates the production of IL10
[11–13, 19, 23, 52, 53], which is known to be
involved in the induction of regulatory
T-lymphocytes [35].
In this study, CTL activity was not detected
in PBMC of pigs that were infected with the
PRRSV LV strain. It is known that different
PRRSV strains may induce differences in
immune responses [19, 29, 40]. Whether the
observations made in this study also account
for PRRSV strains that are different from LV,
remains to be determined.
Upon virus infection, the host immune
response is generally directed into a Th1
response that is specialized in eliminating intra-
cellular pathogens [27]. One of the key cyto-
kines of a Th1 response is IFNc, which is
produced by innate immune effector cells like
NK, cd T-lymphocytes and macrophages, and
by cells of the adaptive immunity, like CD4
Th1 lymphocytes, CTL and memory lympho-
cytes [27]. At 0 dpi, clear IFNc levels were
detected in supernatants of both PRRSV-
restimulated PBMC of pigs 1 and 2, and in
PRV Begonia-restimulated PBMC of pigs 4
and 5. Surprisingly, the IFNc levels were higher
for pigs 1 and 2 than for pigs 4 and 5. It is unli-
kely that the high IFNc level is caused by
PRRSV, since PRRSV restimulation of PBMC
of pig 4 did not result in high IFNc levels. Most
probably, the initial high IFNc levels are rather
due to host-associated factors. After 14 dpi,
only negligible levels of IFNc were detected
in supernatants of PRRSV-restimulated PBMC
of PRRSV-infected pigs, except for pig 1 at
56 dpi, whereas clear IFNc levels were
observed in supernatants of PRV Begonia-
restimulated PBMC of PRV Begonia-infected
pigs. The lack of CTL activity and the lack
of IFNc production in PRRSV-restimulated
PBMC derived from PRRSV-infected pigs sug-
gest an impaired Th1 response upon infection
with PRRSV. Our data support previous reports
on PRRSV-induced cell-mediated immunity in
which only low frequencies of PRRSV-speciﬁc
IFNc-secreting cells were detected in PBMC of
PRRSV-infected pigs during the ﬁrst 2 months
pi [7, 18, 41, 63].
The role of the PRRSV-speciﬁc cell-
mediated immune response in the ﬁnal
resolution of PRRSV infection remains unclear.
Some studies indicate that the PRRSV-speciﬁc
cell-mediated immunity, as assessed by IFNc-
secreting cells, has the potential to protect pigs
from PRRSV infection [65]. However, the lack
of CTL activity detection does not support the
idea of an important role of PRRSV-speciﬁc
CTL in the clearance of PRRSV infection. It
is likely that the present in vitro ﬁndings also
count for the in vivo situation, since PRRSV-
positive cells are still present in lungs of
PRRSV-infected pigs at 35 dpi despite a clear
CD3+CD8high inﬂux in the lungs starting from
10 dpi [31, 49]. The functionality of PRRSV-
speciﬁc CTL might be restored at later time
points, e.g. once the virus load has declined
beyond a certain threshold, as described previ-
ously [64]. In accordance with this, Meier et al.
[41] demonstrated that higher levels of PRRSV-
speciﬁc IFNc-secreting cells only appeared
starting from 25 weeks pi. The CTL activity
and IFNc production that were observed in
pig 1 at 56 dpi also support this assumption.
Most likely, besides PRRSV-neutralizing
antibodies and PRRSV-speciﬁc CTL, other
(immune) mechanisms are involved in
controlling and clearing PRRSV infection.
PRRSV-restimulated PBMC of pig 1 possessed
virus-non-speciﬁc and non-MHC-I-restricted
Impairment of PRRSV-speciﬁc CD3+CD8high cells Vet. Res. (2009) 40:46
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cytolytic activity at 0 and 7 dpi and produced
high levels of IFNc at those time points. Most
likely, the cytolytic activity and the IFNc pro-
duction were caused by innate immune effector
cells, like NK cells or cd T-lymphocytes, in
PBMC of that pig. Starting from day 0 pi until
the end of the experiment, freshly isolated
PBMC of pig 1 possessed 10 to 20% more
cd T-lymphocytes than the other two PRRSV-
infected pigs (data not shown). Whether cd
T-lymphocytes were responsible for the cyto-
toxic effect and the IFNc production in vitro
was not investigated but some data in this study,
such as an inversed correlation between viremia
and the amount of cd T-lymphocytes in freshly
isolated PBMC (data not shown), support this
assumption. Several studies also suggest a role
for the cd T-lymphocyte-mediated non-MHC-
I-restricted cytolytic activity in resolution
of PRRSV infection [7, 36, 44]. However, up
till now, there is no sufﬁcient evidence to consol-
idate this.
In the present study, proliferation of
CD3+CD8high cells was induced in PBMC upon
restimulation with PRRSV. However, neither
PRRSV-speciﬁc CTL activity, nor IFNc produc-
tionwas detected in these PBMC, indicating that
the PBMC did not possess PRRSV-speciﬁc CTL
activity. It remains to be determined whether
there is PRRSV-speciﬁc CTL activity in vivo,
but functional impairment or absence of
PRRSV-speciﬁc CTL in vivo may play a role
in the prolonged presence of PRRSV in its host.
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